COA KVR-2026-6E064D matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
B4H22IFLabel 40 mg · Lab measured 44.21 mg
111% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 11.1 mg using the measured mass, against 10 mg on the label — 11% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-6E064D |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 14 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of MOTS-C from bioedgeresearchlabs.com, performed by Kovera Labs on August 3, 2026. Reported purity: 99.443%. Net content: 44.21 mg against 40 mg labeled (111% of label). Tested content exceeds the labeled amount by 11%. Endotoxins: Pass (≤0.5 EU/mL). Heavy metals: As, Cd, Pb, Hg — all Negative. Batch 061826MOTS40. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 062026MOTS10 | 3 Aug 2026 | Kovera Labs | 99.665% | 104% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion